CA Stock MarketDetailed Quotes

PRM Big Pharma Split Corp

Watchlist
  • 13.040
  • -0.080-0.61%
15min DelayTrading Feb 18 09:54 ET
14.74MMarket Cap13.17P/E (TTM)

Big Pharma Split Corp Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
(FY)Dec 31, 2018
(FY)Dec 31, 2017
Total revenue
-91.60%311.76K
-30.76%3.71M
809.51%5.36M
-83.36%589.26K
-46.96%3.54M
1,539.72%6.68M
407.11K
Non interest income
-91.60%311.76K
-30.76%3.71M
809.51%5.36M
-83.36%589.26K
--3.54M
----
--407.11K
-Fees and commissions
27.33%-230.49K
-21.02%-317.15K
-31.10%-262.06K
16.08%-199.9K
---238.19K
----
---27.85K
-Dividend income
-29.93%767.35K
24.78%1.1M
-4.90%877.62K
1.49%922.88K
--909.32K
----
--31.13K
Credit losses provision
Non interest expense
Selling and administrative expenses
-6.49%334.55K
-3.46%357.76K
71.36%370.56K
-21.66%216.25K
-16.85%276.03K
328.06%331.96K
--77.55K
-General and administrative expense
-6.49%334.55K
-3.46%357.76K
71.36%370.56K
-21.66%216.25K
-16.85%276.03K
328.06%331.96K
--77.55K
Income from associates and other participating interests
Special income (charges)
Other non-operating income (expenses)
Income before tax
-104.44%-139.68K
-35.19%3.15M
1,728.64%4.85M
-91.56%265.42K
13.10%3.14M
760.12%2.78M
323.22K
Income tax
Earnings from equity interest net of tax
Net income
-104.44%-139.68K
-35.19%3.15M
1,728.64%4.85M
-91.56%265.42K
13.10%3.14M
760.12%2.78M
323.22K
Net Income continuous operations
-104.44%-139.68K
-35.19%3.15M
1,728.64%4.85M
-91.56%265.42K
13.10%3.14M
760.12%2.78M
--323.22K
Noncontrolling interests
Net income attributable to the company
-104.44%-139.68K
-35.19%3.15M
1,728.64%4.85M
-91.56%265.42K
13.10%3.14M
760.12%2.78M
323.22K
Preferred stock dividends
-33.11%505.67K
9.99%756.02K
42.37%687.38K
-14.46%482.81K
-16.41%564.43K
5.27%675.23K
641.42K
Other under preferred stock dividend
-43.5K
Net income attributable to common stockholders
-127.01%-645.35K
-43.24%2.39M
2,036.51%4.21M
-108.43%-217.39K
22.57%2.58M
761.50%2.1M
-318.2K
Diluted earnings per share
-133.54%-0.53
-51.68%1.58
1,586.36%3.27
-110.19%-0.22
38.46%2.16
778.26%1.56
-0.23
Basic earnings per share
-133.54%-0.53
-51.68%1.58
1,586.36%3.27
-110.19%-0.22
38.46%2.16
778.26%1.56
-0.23
Dividend per share
0.00%1.2372
0.00%1.2372
0.00%1.2372
0.00%1.2372
33.33%1.2372
0.9279
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
Unqualified Opinion
(FY)Dec 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020(FY)Dec 31, 2019(FY)Dec 31, 2018(FY)Dec 31, 2017
Total revenue -91.60%311.76K-30.76%3.71M809.51%5.36M-83.36%589.26K-46.96%3.54M1,539.72%6.68M407.11K
Non interest income -91.60%311.76K-30.76%3.71M809.51%5.36M-83.36%589.26K--3.54M------407.11K
-Fees and commissions 27.33%-230.49K-21.02%-317.15K-31.10%-262.06K16.08%-199.9K---238.19K-------27.85K
-Dividend income -29.93%767.35K24.78%1.1M-4.90%877.62K1.49%922.88K--909.32K------31.13K
Credit losses provision
Non interest expense
Selling and administrative expenses -6.49%334.55K-3.46%357.76K71.36%370.56K-21.66%216.25K-16.85%276.03K328.06%331.96K--77.55K
-General and administrative expense -6.49%334.55K-3.46%357.76K71.36%370.56K-21.66%216.25K-16.85%276.03K328.06%331.96K--77.55K
Income from associates and other participating interests
Special income (charges)
Other non-operating income (expenses)
Income before tax -104.44%-139.68K-35.19%3.15M1,728.64%4.85M-91.56%265.42K13.10%3.14M760.12%2.78M323.22K
Income tax
Earnings from equity interest net of tax
Net income -104.44%-139.68K-35.19%3.15M1,728.64%4.85M-91.56%265.42K13.10%3.14M760.12%2.78M323.22K
Net Income continuous operations -104.44%-139.68K-35.19%3.15M1,728.64%4.85M-91.56%265.42K13.10%3.14M760.12%2.78M--323.22K
Noncontrolling interests
Net income attributable to the company -104.44%-139.68K-35.19%3.15M1,728.64%4.85M-91.56%265.42K13.10%3.14M760.12%2.78M323.22K
Preferred stock dividends -33.11%505.67K9.99%756.02K42.37%687.38K-14.46%482.81K-16.41%564.43K5.27%675.23K641.42K
Other under preferred stock dividend -43.5K
Net income attributable to common stockholders -127.01%-645.35K-43.24%2.39M2,036.51%4.21M-108.43%-217.39K22.57%2.58M761.50%2.1M-318.2K
Diluted earnings per share -133.54%-0.53-51.68%1.581,586.36%3.27-110.19%-0.2238.46%2.16778.26%1.56-0.23
Basic earnings per share -133.54%-0.53-51.68%1.581,586.36%3.27-110.19%-0.2238.46%2.16778.26%1.56-0.23
Dividend per share 0.00%1.23720.00%1.23720.00%1.23720.00%1.237233.33%1.23720.9279
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------------Unqualified Opinion

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Trending Stocks
Dividend Kings of Canada Dividend Kings of Canada

Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility. Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility.